270 related articles for article (PubMed ID: 27305590)
1. Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)-Infected Recipients.
Shelton BA; Mehta S; Sawinski D; Reed RD; MacLennan PA; Gustafson S; Segev DL; Locke JE
Am J Transplant; 2017 Jan; 17(1):173-179. PubMed ID: 27305590
[TBL] [Abstract][Full Text] [Related]
2. Impact of Protease Inhibitor-Based Anti-Retroviral Therapy on Outcomes for HIV+ Kidney Transplant Recipients.
Sawinski D; Shelton BA; Mehta S; Reed RD; MacLennan PA; Gustafson S; Segev DL; Locke JE
Am J Transplant; 2017 Dec; 17(12):3114-3122. PubMed ID: 28696079
[TBL] [Abstract][Full Text] [Related]
3. Identification of Optimal Donor-Recipient Combinations Among Human Immunodeficiency Virus (HIV)-Positive Kidney Transplant Recipients.
Locke JE; Shelton BA; Reed RD; MacLennan PA; Mehta S; Sawinski D; Segev DL
Am J Transplant; 2016 Aug; 16(8):2377-83. PubMed ID: 27140837
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-Year single center experience.
Camargo JF; Anjan S; Chin-Beckford N; Morris MI; Abbo LM; Simkins J; Ciancio G; Chen LJ; Burke GW; Figueiro J; Guerra G; Kupin WL; Mattiazzi A; Ortigosa-Goggins M; Ram Bhamidimarri K; Roth D
Clin Transplant; 2019 May; 33(5):e13532. PubMed ID: 30866102
[TBL] [Abstract][Full Text] [Related]
5. Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus.
Kucirka LM; Durand CM; Bae S; Avery RK; Locke JE; Orandi BJ; McAdams-DeMarco M; Grams ME; Segev DL
Am J Transplant; 2016 Aug; 16(8):2368-76. PubMed ID: 27111897
[TBL] [Abstract][Full Text] [Related]
6. Pre-Kidney Transplant Lower Extremity Impairment and Post-Kidney Transplant Mortality.
Nastasi AJ; McAdams-DeMarco MA; Schrack J; Ying H; Olorundare I; Warsame F; Mountford A; Haugen CE; González Fernández M; Norman SP; Segev DL
Am J Transplant; 2018 Jan; 18(1):189-196. PubMed ID: 28710900
[TBL] [Abstract][Full Text] [Related]
7. Kidney transplant outcomes in recipients with visual, hearing, physical and walking impairments: a prospective cohort study.
Thomas AG; Ruck JM; Chu NM; Agoons D; Shaffer AA; Haugen CE; Swenor B; Norman SP; Garonzik-Wang J; Segev DL; McAdams-DeMarco M
Nephrol Dial Transplant; 2020 Jul; 35(7):1262-1270. PubMed ID: 31411724
[TBL] [Abstract][Full Text] [Related]
8. Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys.
Bowring MG; Holscher CM; Zhou S; Massie AB; Garonzik-Wang J; Kucirka LM; Gentry SE; Segev DL
Am J Transplant; 2018 Mar; 18(3):617-624. PubMed ID: 29116674
[TBL] [Abstract][Full Text] [Related]
9. Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients.
Locke JE; Reed RD; Mehta SG; Durand C; Mannon RB; MacLennan P; Shelton B; Martin MY; Qu H; Shewchuk R; Segev DL
Am J Transplant; 2015 Aug; 15(8):2096-104. PubMed ID: 25773499
[TBL] [Abstract][Full Text] [Related]
10. Poor Outcomes in Kidney Transplant Candidates and Recipients With History of Falls.
Chu NM; Shi Z; Berkowitz R; Haugen CE; Garonzik-Wang J; Norman SP; Humbyrd C; Segev DL; McAdams-DeMarco MA
Transplantation; 2020 Aug; 104(8):1738-1745. PubMed ID: 32732854
[TBL] [Abstract][Full Text] [Related]
11. Early steroid withdrawal in HIV-infected kidney transplant recipients: Utilization and outcomes.
Werbel WA; Bae S; Yu S; Al Ammary F; Segev DL; Durand CM
Am J Transplant; 2021 Feb; 21(2):717-726. PubMed ID: 32681603
[TBL] [Abstract][Full Text] [Related]
12. Pretransplant CD4 Count Influences Immune Reconstitution and Risk of Infectious Complications in Human Immunodeficiency Virus-Infected Kidney Allograft Recipients.
Suarez JF; Rosa R; Lorio MA; Morris MI; Abbo LM; Simkins J; Guerra G; Roth D; Kupin WL; Mattiazzi A; Ciancio G; Chen LJ; Burke GW; Goldstein MJ; Ruiz P; Camargo JF
Am J Transplant; 2016 Aug; 16(8):2463-72. PubMed ID: 26953224
[TBL] [Abstract][Full Text] [Related]
13. Survival Benefit of Kidney Transplantation in HIV-infected Patients.
Locke JE; Gustafson S; Mehta S; Reed RD; Shelton B; MacLennan PA; Durand C; Snyder J; Salkowski N; Massie A; Sawinski D; Segev DL
Ann Surg; 2017 Mar; 265(3):604-608. PubMed ID: 27768622
[TBL] [Abstract][Full Text] [Related]
14. Depressive symptoms, frailty, and adverse outcomes among kidney transplant recipients.
Konel JM; Warsame F; Ying H; Haugen CE; Mountford A; Chu NM; Crews DC; Desai NM; Garonzik-Wang JM; Walston JD; Norman SP; Segev DL; McAdams-DeMarco MA
Clin Transplant; 2018 Oct; 32(10):e13391. PubMed ID: 30152107
[TBL] [Abstract][Full Text] [Related]
15. Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study.
López-Medrano F; Fernández-Ruiz M; Silva JT; Carver PL; van Delden C; Merino E; Pérez-Saez MJ; Montero M; Coussement J; de Abreu Mazzolin M; Cervera C; Santos L; Sabé N; Scemla A; Cordero E; Cruzado-Vega L; Martín-Moreno PL; Len Ó; Rudas E; de León AP; Arriola M; Lauzurica R; David M; González-Rico C; Henríquez-Palop F; Fortún J; Nucci M; Manuel O; Paño-Pardo JR; Montejo M; Muñoz P; Sánchez-Sobrino B; Mazuecos A; Pascual J; Horcajada JP; Lecompte T; Moreno A; Carratalà J; Blanes M; Hernández D; Fariñas MC; Andrés A; Aguado JM;
Am J Transplant; 2016 Nov; 16(11):3220-3234. PubMed ID: 27105907
[TBL] [Abstract][Full Text] [Related]
16. Renal transplantation in human immunodeficiency virus-infected recipients: a case-control study from the Brazilian experience.
Vicari AR; Spuldaro F; Sandes-Freitas TV; Cristelli MP; Requião-Moura LR; Reusing JO; Pierrotti LC; Oliveira ML; Girão CM; Gadonski G; Kroth LV; Deboni LM; Ferreira GF; Tedesco-Silva H; Esmeraldo R; David-Neto E; Saitovitch D; Keitel E; Garcia VD; Pacheco-Silva A; Medina-Pestana JO; Manfro RC
Transpl Infect Dis; 2016 Oct; 18(5):730-740. PubMed ID: 27503081
[TBL] [Abstract][Full Text] [Related]
17. Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.
Gathogo E; Harber M; Bhagani S; Levy J; Jones R; Hilton R; Davies G; Post FA;
Transplantation; 2016 Apr; 100(4):871-8. PubMed ID: 26413990
[TBL] [Abstract][Full Text] [Related]
18. Fractures and Subsequent Graft Loss and Mortality among Older Kidney Transplant Recipients.
Salter ML; Liu X; Bae S; Chu NM; Miller Dunham A; Humbyrd C; Segev DL; McAdams-DeMarco MA
J Am Geriatr Soc; 2019 Aug; 67(8):1680-1688. PubMed ID: 31059126
[TBL] [Abstract][Full Text] [Related]
19. Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes.
Lentine KL; Lam NN; Naik AS; Axelrod DA; Zhang Z; Dharnidharka VR; Hess GP; Segev DL; Ouseph R; Randall H; Alhamad T; Devraj R; Gadi R; Kasiske BL; Brennan DC; Schnitzler MA
Am J Transplant; 2018 Dec; 18(12):2987-2999. PubMed ID: 29498196
[TBL] [Abstract][Full Text] [Related]
20. De Novo Belatacept in a Human Immunodeficiency Virus-Positive Kidney Transplant Recipient.
Cohen EA; Mulligan D; Kulkarni S; Tichy EM
Am J Transplant; 2016 Sep; 16(9):2753-7. PubMed ID: 27137752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
